5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies

BACKGROUND: Herpes zoster can negatively impact older adults’ health and quality of life. An adjuvanted recombinant zoster vaccine (RZV) has excellent vaccine efficacy (VE), including in older adults. Given that frailty is strongly associated with vulnerability to illness and adverse health outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrew, Melissa K, Kim, Joon Hyung, Matthews, Sean, Dessart, Christophe, levin, myron J, Oostvogels, Lidia, Riley, Megan, Schmader, Kenneth E, McNeil, Shelly, Schuind, Anne, Curran, Desmond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776036/
http://dx.doi.org/10.1093/ofid/ofaa417.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776036/
http://dx.doi.org/10.1093/ofid/ofaa417.004

Ejemplares similares